No effects of a 6-week intervention with a glucagon-like peptide-1 receptor agonist on pancreatic volume and oedema in obese men without diabetes.
Maria S SvaneHelle H JohannesenChristoffer MartinussenKirstine N Bojsen-MøllerMartin Lundsgaard HansenAdam E HansenCarolyn F DeaconBolette HartmannSune H KellerThomas L KlausenAnnika LoftAndreas KjaerSten MadsbadJohan LöfgrenJens J HolstNicolai J Wewer AlbrechtsenPublished in: Diabetes, obesity & metabolism (2020)
Six weeks of treatment with liraglutide did not affect pancreatic volume, oedema or cellularity in obese men without diabetes.